Mindmed converts multiple voting shares to subordinate voting shares

- automatic conversion to be effective march 14, 2022 - new york, feb. 23, 2022 /prnewswire/ -- mind medicine (mindmed) inc. (nasdaq: mnmd), (neo: mmed), (de: mmq) (the "company"), a clinical-stage biopharmaceutical company developing psychedelic-inspired therapies for the treatment of brain-based disorders, announced today  that all the company's issued and outstanding multiple voting shares (the "multiple voting shares") will undergo a mandatory conversion into subordinate voting shares (the "subordinate voting shares") (the "conversion"), in accordance with the company's articles. the conversion will be effective march 14, 2022 (the "effective date").
MNMD Ratings Summary
MNMD Quant Ranking